Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Burning Mouth Syndrome Pain: Randomized Controlled Trial
ChiCTR2500105797Phase 4Not yet recruiting
- Sponsor
- Affiliated Stomatological Hospital of Guilin Medical University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pregabalin in glossodynia (BMS) (2 arms), sponsored by Affiliated Stomatological Hospital of Guilin Medical University. Primary endpoint: Visual analog scale for pain. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on ChiCTR2500105797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105797.